Retrospective comparison of clofarabine versus fludarabine in combination with high-dose cytarabine with or without granulocyte colony-stimulating factor as salvage therapies for acute myeloid leukemia

We recently reported that clofarabine, high-dose cytarabine, and granulocyte colony-stimulating factor (GCLAC) produced a 46% complete remission rate in relapsed/refractory acute myeloid leukemia. GCLAC differs from FLAG by substitution of clofarabine for fludarabine, raising the question of the rel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Becker, Pamela S., Kantarjian, Hagop M., Appelbaum, Frederick R., Storer, Barry, Pierce, Sherry, Shan, Jianqin, Faderl, Stephan, Estey, Elihu H.
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2013
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3533672/
https://ncbi.nlm.nih.gov/pubmed/22801963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.063438
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados